Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dolby LaboratoriesMEX:DLB 73 Debt-to-EBITDA is 0.09 as of Mar. 2026, which is 40% below its 10-year median of 0.15. GuruFocus rates MEX:DLB with a GF Score™ of 73/100 and a GF Value™ of MXN1,548.00. The stock has 2 warning signs investors should review. Among 834 Business Services companies, Dolby Laboratories ranks better than 89.57% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Dolby Laboratories's Debt-to-EBITDA or its related term are showing as below:
MEX:DLB'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.1 Med: 0.15 Max: 0.23
Current: 0.13
During the past 13 years, the highest Debt-to-EBITDA Ratio of Dolby Laboratories was 0.23. The lowest was 0.10. And the median was 0.15.
MEX:DLB's Debt-to-EBITDA is ranked better than 89.57% of 834
companies
in the Business Services industry
Industry Median: 1.66
vs MEX:DLB: 0.13
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Dolby Laboratories Debt-to-EBITDA Related Terms
Dolby Laboratories Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Dolby Laboratories's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:DLB vs AZZ, UNF, AMTM: Debt-to-EBITDA Comparison
For the Specialty Business Services subindustry, Dolby Laboratories's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dolby Laboratories Debt-to-EBITDA vs Business Services Industry
For the Business Services industry and Industrials sector, Dolby Laboratories's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Dolby Laboratories's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
Dolby Laboratories (MEX:DLB) has a Debt-to-EBITDA of 0.09 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dolby Laboratories. This is 40% below median its historical median of 0.15. Over the past decade, Dolby Laboratories' Debt-to-EBITDA has ranged from 0.10 to 0.23. According to the industry distribution chart, Dolby Laboratories ranks #87 out of 834 companies in the Business Services industry, placing it in the top 10.4%.
Is Dolby Laboratories' Debt-to-EBITDA too high?
Dolby Laboratories' current Debt-to-EBITDA of 0.09 is 40% below median its 10-year median of 0.15. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 0.23. The Business Services industry median Debt-to-EBITDA is 1.66. Dolby Laboratories' value of 0.09 is 94.6% below this industry median. Based on the distribution chart, Dolby Laboratories ranks #87 out of 834 companies in the Business Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dolby Laboratories has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Dolby Laboratories' Debt-to-EBITDA compare to AZZ and UNF?
According to the Business Services industry distribution chart, Dolby Laboratories ranks #87 out of 834 companies for Debt-to-EBITDA. This places Dolby Laboratories in the top 10% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 1.66. Dolby Laboratories' value of 0.09 is 94.6% below this benchmark. Historically, Dolby Laboratories' own Debt-to-EBITDA has ranged from 0.10 to 0.23 over the past decade. While the company's 10-year median is 0.15 vs. the industry median of 1.66, Dolby Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Business Services company?
The median Debt-to-EBITDA among Business Services companies is 1.66, based on 834 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dolby Laboratories's current Debt-to-EBITDA of 0.09 is 94.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Dolby Laboratories. For the Business Services industry, the median Debt-to-EBITDA is 1.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dolby Laboratories's current Debt-to-EBITDA is 0.09, which is 40% below median its own 10-year median of 0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dolby Laboratories stock overvalued right now?
Dolby Laboratories (MEX:DLB) has a current Debt-to-EBITDA of 0.09. The stock's GF Value™ is MXN1,548.00, compared to a current price of MXN933.45 — trading 39.7% below its estimated fair value. The current Debt-to-EBITDA is 0.09, which is 40% below median its 10-year median of 0.15 and 94.6% below the Business Services industry median of 1.66. Dolby Laboratories' overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Dolby Laboratories (MEX:DLB), the current Debt-to-EBITDA is 0.09 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dolby Laboratories (MEX:DLB) Overvalued in 2026?
Based on GuruFocus' analysis, Dolby Laboratories stock appears to be undervalued.
The current stock price of MXN933.45 is trading 39.7% below its estimated GF Value™ of MXN1,548.00.
Key valuation signals for MEX:DLB:
Debt-to-EBITDA: 0.09 (40% below median its 10-year median of 0.15)
GF Value™: MXN1,548.00 vs. price of MXN933.45 (39.7% below fair value)
Industry Position: 94.6% below the Business Services median (#87 of 834)
No single metric tells the full story. See the MEX:DLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.
73GF Score
Get the complete analysis for MEX:DLB
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:DLB has been successfully added to your 
